Page last updated: 2024-10-22

ag-1296 and Benign Neoplasms, Brain

ag-1296 has been researched along with Benign Neoplasms, Brain in 1 studies

6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Watanabe, T1
Ohtani, T1
Aihara, M1
Ishiuchi, S1

Other Studies

1 other study available for ag-1296 and Benign Neoplasms, Brain

ArticleYear
Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
    Journal of neurosurgery, 2013, Volume: 118, Issue:4

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Model

2013